Li Renjie, Fu Yao, Peng Shan, Yang Fengjiao, Ai Shuyue, Wang Feng, Zhang Shun, Guo Hongqian, Qiu Xuefeng
Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Institute of Urology, Nanjing University, Nanjing, 210008, China.
Eur J Nucl Med Mol Imaging. 2025 Feb 17. doi: 10.1007/s00259-025-07148-8.
The aim of this study was to investigate the radiological and pathological characteristics of false-positive lesions on [Ga]Ga-PSMA-11 PET/CT during the primary staging of prostate cancer.
This study retrospectively analyzed 216 prostate cancer patients who had [Ga]Ga-PSMA-11 PET/CT before radical prostatectomy. False-positive lesion was defined as suspicious lesion with PRIMARY score ≥ 3 on PET/CT but benign on whole-mount pathology. To analyze the radiological and pathological features of false-positive lesions, no-uptake areas on PSMA PET/CT with benign pathology on the whole-mount specimen were randomly delineated and defined as true-negative lesions. The pathological features of false-positive and true-negative lesions were compared using Fisher's exact test. The differences of SUVmax and SUVmean between false-positive and true-positive lesions were determined and compared using the Wilcoxon matched-pairs signed-ranks test. In addition, PSMA expression in false-positive lesions was assessed by immunohistochemistry.
A total of 36 false-positive lesions were identified on [Ga]Ga-PSMA-11 PET/CT: 25 (69.44%) were simple atrophy with cyst formation, 7 (19.44%) were prostatic nodular hyperplasia, 3 (8.33%) were inflammation and 1 (2.78%) was normal glands. A comparable number of 36 true-negative lesions were delineated: 21 (58.33%) were normal glands, 8 (22.22%) were simple atrophy with cyst formation, 6 (16.67%) were prostatic nodular hyperplasia, and 1 (2.78%) were inflammation. The Fisher's exact test revealed a statistically significant difference in the prevalence of simple atrophy with cyst formation between false-positive and true-negative lesions (69.44% vs. 22.22%; P < 0.001). Differences in SUVmax and SUVmean between false-positive and true-positive lesions were also statistically significant (both P < 0.001). PSMA expression in false-positive lesions was confirmed via immunohistochemistry.
This study determined that simple atrophy with cyst formation is a distinctive pathological feature of false-positive lesions on [Ga]Ga-PSMA-11 PET/CT. This observation is likely attributable to the elevated PSMA expression in simple atrophy with cyst formation, as confirmed by histological analysis. Additionally, false-positive lesions were found to have significantly lower SUV compared to true-positive lesions.
本研究旨在探讨[镓]Ga-PSMA-11 PET/CT在前列腺癌初次分期时假阳性病变的影像学和病理学特征。
本研究回顾性分析了216例在前列腺癌根治术前接受[镓]Ga-PSMA-11 PET/CT检查的前列腺癌患者。假阳性病变定义为PET/CT上PRIMARY评分≥3的可疑病变,但在全层病理检查中为良性。为分析假阳性病变的影像学和病理学特征,在PSMA PET/CT上无摄取且全层标本病理为良性的区域被随机划定并定义为真阴性病变。使用Fisher精确检验比较假阳性和真阴性病变的病理学特征。使用Wilcoxon配对符号秩检验确定并比较假阳性和真阳性病变之间SUVmax和SUVmean的差异。此外,通过免疫组织化学评估假阳性病变中的PSMA表达。
在[镓]Ga-PSMA-11 PET/CT上共识别出36例假阳性病变:25例(69.44%)为伴有囊肿形成的单纯萎缩,7例(19.44%)为前列腺结节样增生,3例(8.33%)为炎症,1例(2.78%)为正常腺体。划定了数量相当的36例真阴性病变:21例(58.33%)为正常腺体,8例(22.22%)为伴有囊肿形成的单纯萎缩,6例(16.67%)为前列腺结节样增生,1例(2.78%)为炎症。Fisher精确检验显示,假阳性和真阴性病变中伴有囊肿形成的单纯萎缩的患病率存在统计学显著差异(69.44%对22.22%;P<0.001)。假阳性和真阳性病变之间SUVmax和SUVmean的差异也具有统计学显著性(均P<0.001)。通过免疫组织化学证实了假阳性病变中的PSMA表达。
本研究确定伴有囊肿形成的单纯萎缩是[镓]Ga-PSMA-11 PET/CT上假阳性病变的一个独特病理学特征。组织学分析证实,这一观察结果可能归因于伴有囊肿形成的单纯萎缩中PSMA表达升高。此外,发现假阳性病变的SUV明显低于真阳性病变。